Role of Platelet Glycoprotein VI and Tyrosine Kinase Syk in Thrombus Formation on Collagen-Like Surfaces

Int J Mol Sci. 2019 Jun 7;20(11):2788. doi: 10.3390/ijms20112788.

Abstract

Platelet interaction with collagens, via von Willebrand factor, is a potent trigger of shear-dependent thrombus formation mediated by subsequent engagement of the signaling collagen receptor glycoprotein (GP)VI, enforced by integrin α2β1. Protein tyrosine kinase Syk is central in the GPVI-induced signaling pathway, leading to elevated cytosolic Ca2+. We aimed to determine the Syk-mediated thrombogenic activity of several collagen peptides and (fibrillar) type I and III collagens. High-shear perfusion of blood over microspots of these substances resulted in thrombus formation, which was assessed by eight parameters and was indicative of platelet adhesion, activation, aggregation, and contraction, which were affected by the Syk inhibitor PRT-060318. In platelet suspensions, only collagen peptides containing the consensus GPVI-activating sequence (GPO)n and Horm-type collagen evoked Syk-dependent Ca2+ rises. In whole blood under flow, Syk inhibition suppressed platelet activation and aggregation parameters for the collagen peptides with or without a (GPO)n sequence and for all of the collagens. Prediction models based on a regression analysis indicated a mixed role of GPVI in thrombus formation on fibrillar collagens, which was abolished by Syk inhibition. Together, these findings indicate that GPVI-dependent signaling through Syk supports platelet activation in thrombus formation on collagen-like structures regardless of the presence of a (GPO)n sequence.

Keywords: calcium; collagen; glycoprotein VI; platelet activation; protein tyrosine kinase; thrombus.

MeSH terms

  • Blood Platelets / drug effects
  • Blood Platelets / metabolism*
  • Blood Platelets / physiology
  • Cells, Cultured
  • Collagen / chemistry
  • Collagen / metabolism*
  • Cyclohexylamines / pharmacology
  • Humans
  • Peptide Fragments / chemistry
  • Peptide Fragments / metabolism
  • Platelet Aggregation
  • Platelet Membrane Glycoproteins / metabolism*
  • Protein Kinase Inhibitors / pharmacology
  • Pyrimidines / pharmacology
  • Syk Kinase / antagonists & inhibitors
  • Syk Kinase / metabolism*
  • Thrombosis / metabolism*

Substances

  • 2-(2-aminocyclohexylamino)-4-(m-tolylamino)pyrimidine-5-carboxamide
  • Cyclohexylamines
  • Peptide Fragments
  • Platelet Membrane Glycoproteins
  • Protein Kinase Inhibitors
  • Pyrimidines
  • platelet membrane glycoprotein VI
  • Collagen
  • SYK protein, human
  • Syk Kinase